Published in J Nucl Med on March 01, 1995
Have we overestimated the benefit of human(ized) antibodies? MAbs (2010) 1.05
Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. Br J Cancer (1999) 0.82
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer. Clin Cancer Res (2008) 0.81
Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. BMC Cancer (2004) 0.80
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS (2001) 5.52
Mouse thymus-independent and thymus-derived lymphoid cells. I. Immunofluorescent and functional studies. J Exp Med (1972) 2.96
Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J Immunol (1978) 2.65
Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. N Engl J Med (1980) 2.50
Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev (1980) 2.32
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
Secretory IgA, a major immunoglobulin in most bovine external secretions. J Immunol (1971) 2.09
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol (1999) 2.03
Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry (1972) 2.02
Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J (2012) 2.01
In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (1974) 1.96
Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels. Leukemia (2007) 1.89
Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J Nucl Med (1990) 1.85
Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol (1979) 1.82
Mouse bone marrow lymphocytes and their differentiation. J Immunol (1974) 1.66
Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate (1997) 1.63
Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med (1983) 1.63
Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). Lancet (1974) 1.60
In vitro combination of human and bovine free secretory component with IgA of various species. Nature (1970) 1.59
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther (2009) 1.57
Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res (1980) 1.51
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat Med (1998) 1.50
Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis. Metabolism (1999) 1.48
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein. Br J Clin Pharmacol (2006) 1.46
Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest (2001) 1.46
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line. EMBO J (1982) 1.46
Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants. Support Care Cancer (2000) 1.45
Mouse thymus-independent and thymus-derived lymphoid cells. II. Ultrastructural studies. J Exp Med (1972) 1.43
IgA with "secretory piece" in bovine colostrum and saliva. Nature (1969) 1.42
Nuclear cardiology: a European perspective. J Nucl Cardiol (1999) 1.40
The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg (1987) 1.40
Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry (1973) 1.40
Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines. Proc Natl Acad Sci U S A (1980) 1.39
Secretory IgA in human serum. J Immunol (1970) 1.32
Placental pathologic findings in preterm birth. Am J Obstet Gynecol (1991) 1.32
Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa. Immunochemistry (1977) 1.30
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin Chem (2001) 1.27
Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25
The area of attachment of cytotoxic T lymphocytes to their target cells shows high motility and polarization of actin, but not myosin. J Immunol (1982) 1.23
Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol (1984) 1.23
Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res (1994) 1.23
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res (1987) 1.22
The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer (2005) 1.22
Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL. Eur J Immunol (1986) 1.22
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med (2001) 1.19
Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol (1989) 1.17
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res (1983) 1.16
Recurrence of alveolar echinococcosis in the liver graft after liver transplantation. Hepatology (1992) 1.15
Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J Clin Invest (1986) 1.13
The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells. J Immunol (1985) 1.13
Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability. Br J Cancer (2008) 1.13
An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium. Infect Immun (1993) 1.12
Influence of perinatal, developmental and environmental factors on cognitive abilities of preterm children without major impairments at 5 years. Early Hum Dev (1995) 1.11
Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proc Natl Acad Sci U S A (1992) 1.11
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.10
A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity. J Travel Med (2001) 1.10
Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol (1983) 1.10
Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int J Cancer (1993) 1.10
Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer (1984) 1.09
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers. J Interferon Cytokine Res (2000) 1.09
Laparoscopic treatment of acute small bowel obstruction: a multicentre retrospective study. ANZ J Surg (2001) 1.09
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. J Neuroimmunol (1999) 1.09
Provider characteristics and behaviors as predictors of immunization coverage. Am J Prev Med (2001) 1.07
Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol (1992) 1.07
Established murine cytolytic T-cell lines as tools for a somatic cell genetic analysis of T-cell functions. Immunol Rev (1980) 1.07
Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer (1991) 1.07
Antigenic sites in carcinoembryonic antigen. Cancer Res (1989) 1.06
Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study. Int J Cancer (1999) 1.06
Identification of secretory IgA, free secretory piece and serum IgA in the ovine and caprine species. Immunochemistry (1970) 1.06
Limiting dilution analysis of alloantigen-reactive T lymphocytes. III. Effect of priming on precursor frequencies. J Immunol (1979) 1.05
Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr Opin Immunol (1991) 1.03
Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int J Cancer (1988) 1.03
Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet (1996) 1.03
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol (1999) 1.03
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability. Ther Drug Monit (2001) 1.02
Demonstration of HLA-DR antigens in normal human brain. J Neurol Neurosurg Psychiatry (1984) 1.01
Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. J Clin Invest (1989) 1.00
Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay. Cancer (1978) 1.00
"Peptabody": a new type of high avidity binding protein. Proc Natl Acad Sci U S A (1997) 1.00
Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Cancer Res (1983) 0.99
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Ann Oncol (2009) 0.99
Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma. J Immunol (1986) 0.99
Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. Br J Cancer (2001) 0.99
Preterm delivery: correlations of fetal growth and placental pathology. Am J Perinatol (1992) 0.99
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
Use of limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. Oncodev Biol Med (1980) 0.99
Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient. J Antimicrob Chemother (2004) 0.98
Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg (1999) 0.98
Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes. Pharmacogenetics (1997) 0.98
Mechanism of target cell lysis of cytolytic T lymphocytes. I. Characterization of specific lymphocyte-target cell conjugates separated by velocity sedimentation. Eur J Immunol (1977) 0.97
[Pendulous goiter. Thoracic goiter. Reflections apropos of a consecutive series of 61 cases]. J Chir (Paris) (1967) 0.97
In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med (1990) 0.97
Elevated CA125 levels in patients with metastatic breast carcinoma. Br J Cancer (1990) 0.96